New vaccine platform promotes rare protective B cells
Based on a virus-like particle built with a DNA scaffold, the approach could generate broadly neutralizing antibody responses against HIV or influenza.
3 Questions: Using AI to accelerate the discovery and design of therapeutic drugs
Professor James Collins discusses how collaboration has been central to his research into combining computational predictions with new experimental platforms.
Katie Spivakovsky wins 2026 Churchill Scholarship
The MIT senior will pursue a master’s degree at Cambridge University in the U.K. this fall.
New tissue models could help researchers develop drugs for liver disease
Two models more accurately replicate the physiology of the liver, offering a new way to test treatments for fat buildup.
Designing the future of metabolic health through tissue-selective drug delivery
Founded by three MIT alumni, Gensaic uses AI-guided protein design to deliver RNA and other therapeutic molecules to specific cells or areas of the body.
Bryan Bryson: Engineering solutions to the tough problem of tuberculosis
By analyzing how Myobacterium tuberculosis interacts with the immune system, the associate professor hopes to find new vaccine targets to help eliminate the disease.
Akorfa Dagadu named 2027 Schwarzman Scholar
The MIT senior will spend the 2026-27 year at Tsinghua University in Beijing, studying global affairs.
Eighteen MIT faculty honored as “Committed to Caring” for 2025-27
The program recognizes outstanding mentorship of graduate students.
AI-generated sensors open new paths for early cancer detection
Nanoparticles coated with molecular sensors could be used to develop at-home tests for many types of cancer.
Sean Luk: Addressing the urgent need for better immunotherapy
The MIT senior helps design proteins that spur the immune system to fight cancer and other diseases.
MIT-Hood Pediatric Innovation Hub convenes leaders to advance pediatric health
The Hood Pediatric Innovation Hub brings together clinicians, researchers, and industry to bridge the gap between discovery and care.
New study suggests a way to rejuvenate the immune system
Stimulating the liver to produce some of the signals of the thymus can reverse age-related declines in T-cell populations and enhance response to vaccination.
A new immunotherapy approach could work for many types of cancer
Using new molecules that block an immune checkpoint, researchers showed they could stimulate a strong anti-tumor immune response.
MIT HEALS leadership charts a bold path for convergence in health and life sciences
Angela Koehler, Iain Cheeseman, and Katharina Ribbeck are shaping the collaborative as a platform for transformative research, translation, and talent development across MIT.
A better DNA material for genetic medicine
With its circular single-stranded DNA molecules, MIT spinout Kano Therapeutics plans to make gene and cell therapies safer and more effective.